Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

By D. Jabs, J. Rosenbaum, C. Foster, G. Holland, G. Jaffe, J. Louie, R. Nussenblatt, E. Stiehm, H. Tessler, R. V. Van Gelder and 2 more. American journal of ophthalmology-glaucoma, 2000

1,009 citations recorded by the source corpus.

Subfields: Ophthalmology, Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/a1118f8dddb0fb2743bb4ffac6d2298467ee65b2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Yu
2. R. Mahdi
3. A. Amadi-Obi
4. Grace Clarke
5. Y. Lee
6. Xuebin Liu
7. R. Nussenblatt
8. C. Egwuagu

Citations in the corpus

• TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 (2007, background): “Scleritis is a sight-threatening idiopathic inflammatory ocular disease that is often associated with life-threatening systemic disease”